Review Article
Volume 10 Issue 7 - 2021
Impact COVID-19 Infection in Childhood Asthma. Review Study
Dimitrios Kiriazopoulos1 and Ioannis Drikos1,2*
1Department of Pediatrics, Thriasio General Hospital of Elefsina, Elefsina, Greece
2Associate Professor, West Attica University, Ag. Spyridonos, Egaleo, Athens, Greece
*Corresponding Author: Ioannis Drikos, Department of Pediatrics, Thriasio General Hospital of Elefsina, Elefsina and Associate Professor, West Attica University, Ag. Spyridonos, Egaleo, Athens, Greece.
Received: May 28, 2021; Published: June 17, 2021


Between December 2019 and first months of 2020 a novel coronavirus called nCoV2019 and SARS-CoV-2 rapidly spreads from city of Wuhan (China) to every country around the world caused Coronavirus Disease 2019 (COVID-19). Children can be affected by COVID-19 and present mild and generally less severe respiratory symptoms than adults. The percentage of pediatric cases is certainly underestimated. Admission of children to Intensive Care Unit (ICU) is rare and prognosis is favorable except very few cases. We aimed to perform a review study analysis about COVID-19 and childhood asthma. An analysis of electronic databases was performed using PubMed, Cochrane library and Embase and searched up to June 2020. The literature review was conducted independently by two reviewers and analyzed 43 published articles. The available information’s were limited, with few sources suggesting an under-representation and increased risk for severe COVID complications especially in patients with asthma associated with disease severity. The published data of COVID severity infection due to asthma in children are till now extremely rare.

COVID-19 doesn’t have a significant impact on childhood asthma and there is no indication to change treatment strategies for asthmatic children. Furthermore, asthmatic children recommended continuing their therapies without making any dose adjustments.

Keywords: Coronavirus; COVID-19; Pandemic; Asthma; Children


  1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 (2020).
  2. Guo Y., et al. “The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status”. Military Medical Research 13 (2020): 1-11.
  3. Eurosurveillance editorial team. Updated rapid risk assessment from ECDC on the outbreak of COVID-19: increased transmission globally”. Eurosurveillance12 (2020): 2003121.
  4. Angel DM., et al. “JACI: In Practice Response to COVID-19 Pandemic”. The Journal of Allergy and Clinical Immunology: In Practice 5 (2020): 1475-1476.
  5. Zhang JJ., et al. “Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China”. Allergy 7 (2020): 1730-1741.
  6. Center of Disease Control. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases.
  7. Zhao Y., et al. “Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2”. American Journal of Respiratory and Critical Care Medicine 5 (2020): 756-759.
  8. Imai Y., et al. “Angiotensin-converting enzyme 2 in acute respiratory distress syndrome”. Cellular and Molecular Life Sciences 64 (2007): 2006-2012.
  9. Hamming I., et al. “Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis”. The Journal of Pathology 203 (2004): 631-637.
  10. Huang KJ., et al. “An Interferon-g-Related Cytokine Storm in SARS Patients”. Journal of Medical Virology 75 (2005): 185-194.
  11. Berger A. “Science commentary: Th1 and Th2 responses: what are they?” BMJ 321 (2000): 424.
  12. He L., et al. “Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV- infected ACE2 cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS”. The Journal of Pathology 210 (2006): 288-297.
  13. Castillo JR., et al. “Asthma exacerbations: pathogenesis, prevention and treatment”. Journal of Allergy and Clinical Immunology: In Practice 4 (2017): 918-927.
  14. Masoli M., et al. “The global burden of asthma: executive summary of the GINA Dissemination Committee Report”. Allergy 59 (2004): 469-478.
  15. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”. The Lancet Respiratory Medicine 5 (2017): 691-706.
  16. Selroos O., et al. “National and regional asthma programmes in Europe”. The European Respiratory Review 24 (2015): 474-483.
  17. Papadopoulos NG., et al. “The role of respiratory viruses in the origin and exacerbations of asthma”. Current Opinion in Allergy and Clinical Immunology 3 (2003): 39-44.
  18. Papadopoulos NG., et al. “Viruses and bacteria in acute asthma exacerbations – A GA2LEN-DARE* systematic review”. Allergy 66 (2011): 458-468.
  19. Leino A., et al. “Pulmonary function and bronchial reactivity 4 years after the first virus induced wheezing”. Allergy 74 (2019): 518-526.
  20. Zheng XY., et al. “Regional, age and respiratory secretion specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review”. Archives of Virology 163 (2018): 845-853.
  21. Brusselle G., et al. “Allergen-induced Airway Inflammation and Bronchial Responsiveness in Wild-type and Interleukin-4-deficient Mice”. American Journal of Respiratory Cell and Molecular Biology 12 (1995): 254-259.
  22. Gavett SH., et al. “Interleukin 12 Inhibits Antigen-induced Airway Hyperresponsiveness, Inflammation, and Th2 Cytokine Expression in Mice”. Journal of Experimental Medicine 182 (1995): 1527-1536.
  23. Barnes PJ. “Targeting cytokines to treat asthma and chronic obstructive pulmonary disease”. Nature Reviews Immunology 18 (2018): 454-466.
  24. Fahy JV. “Type 2 inflammation in asthma - present in most, absent in many”. Nature Reviews Immunology1 (2015): 57-65.
  25. Pividori M., et al. “Shared and distinct genetic risk factors for childhood- onset and adult-onset asthma: genome-wide and transcriptome-wide studies”. The Lancet Respiratory Medicine 7 (2019): 509-522.
  26. Jartti T., et al. “Role of viruses in asthma”. Seminars in Immunopathology 42 (2020): 61-74.
  27. Dong Y., et al. “Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China”. The Journal of Emergency Medicine 4 (2020): 712-713.
  28. Lu X., et al. “SARS-CoV-2 Infection in Children”. The New England Journal of Medicine 382 (2020): 1663-1665.
  29. Lupia T., et al. “2019 novel coronavirus (2019-nCoV) outbreak: A new challenge”. Journal of Global Antimicrobial Resistance 21 (2020): 22-27.
  30. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 15 (2020): 497-506.
  31. Ludvigsson JF. “Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults”. Acta Paediatr 6 (2020): 1088-1095.
  32. Zheng F., et al. “Clinical characteristics of children with coronavirus disease 2019 in Hubei, China”. Current Medical Science 40 (2020): 275-280.
  33. Li X., et al. “Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan”. The Journal of Allergy and Clinical Immunology 1 (2020): 110-118.
  34. Dong X., et al. “Eleven faces of coronavirus disease 2019”. Allergy7 (2020): 1699-1709.
  35. Nicholls JM., et al. “Lung pathology of fatal severe acute respiratory syndrome”. Lancet 361 (2003): 1773-1778.
  36. Jorens PG., et al. “Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS”. Cytokine 4 (1992): 592-597.
  37. Van Bever HP., et al. “Childhood severe acute respiratory syndrome, coronavirus infections and asthma”. Pediatric Allergy and Immunology 15 (2004): 206-209.
  38. Franceschi C., et al. “Inflamm-aging An Evolutionary Perspective on Immunosenescence”. Annals of the New York Academy of Sciences 1 (2000): 244-254.
  39. Harris TB., et al. “Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly”. The American Journal of Medicine 106 (1999): 506-512.
  40. Mehta P., et al. “COVID-19: consider cytokine storm syndromes and immunosuppression”. Lancet 395 (2020): 1033-1034.
  41. Ruan Q., et al. “Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China”. Intensive Care Medicine 6 (2020): 1294-1297.
  42. Xie X., et al. “Age- and gender-related difference of ACE2 expression in rat lung”. Life Sciences19 (2006): 2166-2171.
  43. World Allergy Organization. Allergic patients during COVID-19 pandemic (2020).
  44. Niederman MS., et al. “Rising to the challenge of the novel SARS-coronavirus-2 (SARS-CoV-2): Advice for pulmonary and critical care and an agenda for research”. American Journal of Respiratory and Critical Care Medicine9 (2020): 1019-1022.
  45. Bhatraju PK., et al. “Covid-19 in Critically Ill Patients in the Seattle Region - Case Series”. The New England Journal of Medicine21 (2020): 2012-2022.
  46. Lee N., et al. “Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients”. Journal of Clinical Virology 31 (2004): 304-309.
  47. Arabi YM., et al. “Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome”. American Journal of Respiratory and Critical Care Medicine 197 (2018): 757-767.
  48. Shaker MS., et al. “COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic”. The Journal of Allergy and Clinical Immunology: In Practice5 (2020): 1477-1488.
  49. Bousquet J., et al. “Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement”. Allergy (2020).
Citation: Dimitrios Kiriazopoulos and Ioannis Drikos. “Impact COVID-19 Infection in Childhood Asthma. Review Study”. EC Paediatrics 10.7 (2021): 44-51.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 09, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.